Why ImmunityBio, Inc. (IBRX) Is the Top Small Cap Stock to Buy

W e recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential.In this article, we are going to take a look at where ImmunityBio, Inc. …

$100
OFF

ImmunityBio Stock: Forging A New Plan After Recent $100 Million ...

2 weeks from now

Dec 16, 2024 · Learn why IBRX stock is a Buy. ... Top Small Cap Stocks; Stocks by Quant; Most Shorted Stocks; ... Dec. 16, 2024 12:24 AM ET ImmunityBio, Inc. (IBRX) Stock 23 Comments. …

seekingalpha.com

00%
OFF

Immunitybio Inc (IBRX) Stock Price & News - Google Finance

2 weeks from now

TG Therapeutics Inc common stock. $27.67. TGTX 0.00%. ... Why ImmunityBio, Inc. (IBRX) Is the Top Small Cap Stock to Buy with the Highest Upside Potential ... Top 10 Small Cap Stocks to …

google.com

38%
OFF

BTIG Initiates Coverage Of ImmunityBio (IBRX) With Buy ... - Nasdaq

2 weeks from now

Dec 23, 2024 · Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.. Analyst Price Forecast Suggests 499.38% …

nasdaq.com

38%
OFF

BTIG Initiates Coverage Of ImmunityBio (IBRX) With Buy …

2 weeks from now

Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation. Analyst Price Forecast Suggests 499.38% …

msn.com

600%
OFF

Immunitybio Inc. (IBRX): Among The Most Promising Cancer Stocks …

2 weeks from now

In October, EF Hutton initiated coverage of ImmunityBio, Inc. (NASDAQ:IBRX) with a Buy rating and a $30 price target, an upside of over 600%, reflecting confidence in the company’s potential.

msn.com

20%
OFF

Here's Why ImmunityBio (IBRX) Is A Great 'Buy The Bottom' Stock …

2 weeks from now

Dec 4, 2023 · If this is not enough, you should note that IBRX currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on …

zacks.com

$6
OFF

ImmunityBio Initiated With A Buy At BTIG | Markets Insider

2 weeks from now

6 days ago · BTIG analyst Justin Zelin initiated coverage of ImmunityBio (IBRX) with a Buy rating and $6 price target Lead product Anktiva is approved in BCG-unresponsive non-muscle …

businessinsider.com

2%
OFF

ImmunityBio (NASDAQ:IBRX) Trading Down 5.2% - What's Next?

2 weeks from now

2 days ago · Finally, EF Hutton Acquisition Co. I raised ImmunityBio to a "strong-buy" rating in a research report on Wednesday, October 23rd. Check Out Our Latest Research Report on …

marketbeat.com

22%
OFF

ImmunityBio (IBRX) P/E Ratio: Current & Historical Analysis

2 weeks from now

The P/E ratio for ImmunityBio (IBRX) is -2.62 as of Jan 14, 2025.This represents a decrease of-48.22% compared to its 12-month average P/E ratio of-5.06.A higher P/E ratio suggests that …

public.com

6%
OFF

ImmunityBio (NASDAQ:IBRX) Stock Price Down 5.6% - Here's Why

2 weeks from now

Dec 31, 2024 · ImmunityBio, Inc. (NASDAQ:IBRX - Get Free Report) fell 5.6% during trading on Tuesday . The stock traded as low as $2.51 and last traded at $2.53. 3,579,558 shares were …

marketbeat.com

FAQs about Why ImmunityBio, Inc. (IBRX) Is the Top Small Cap Stock to Buy Coupon?

How much is immunitybio (IBRX) stock now?

ImmunityBio's stock was trading at $2.56 on January 1st, 2025. Since then, IBRX stock has increased by 9.8% and is now trading at $2.81. How do I buy shares of ImmunityBio? Shares of IBRX stock can be purchased through any online brokerage account. ...

Is immunitybio a good stock to buy?

ImmunityBio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 1 hold rating, and no sell ratings. ImmunityBio has only been the subject of 2 research reports in the past 90 days. Read more about ImmunityBio's stock forecast and price target. Earnings and Valuation 0.6 / 5Proj. ...

Does immunitybio (IBRX) have a short interest %?

NEW YORK , July 25, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ImmunityBio, Inc. (NASDAQ: IBRX) breached their ... IBRX has a short interest % of the float of 33%, superior to GME at 21%. Investors should keep an eye on it for short squeeze-fueled volatility. ...

What is immunitybio (IBRX)?

Market Cap: $1.94 billion ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company that develops next-generation therapies to treat cancer and infectious diseases. Its immunotherapy platform activates the adaptive and innate immune systems to create long-term immunological memory. ...

Does IBRX have company insights?

IBRX does not have Company Insights Find the latest ImmunityBio, Inc. (IBRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ...

How much is IBRX stock worth?

Since then, IBRX stock has increased by 9.8% and is now trading at $2.81. How do I buy shares of ImmunityBio? Shares of IBRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. ...